Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A

Meetings and Events

Grand Rounds

Click here to view upcoming grand rounds.

Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - December 2016 (PDF)  


Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue.

Submit your milestones and comments.

Key Changes Coming to Medicare Payment Model

As part of a federal effort to streamline regulations and improve healthcare value and quality, the Medicare payment model will undergo significant change beginning Jan. 1. Under the new rules, eligible clinicians must participate in one of two payment tracks. More than 85 percent of physicians will work with the Merit-Based Incentive Payment System, while the remainder will use the Advanced Alternative Payment Model.

» Read more

$1.2 Million State Precision Medicine Grant

Cedars-Sinai health investigators will use a $1.2 million grant from a state precision medicine initiative to design a system using remote monitoring to predict heart attacks and other cardiovascular events. Among the data collected will be activity, sleep, heart rate and stress levels. The co-principal investigators are Brennan M. Spiegel, MD; C. Noel Bairey Merz, MD; and Jennifer Van Eyk, PhD.

» Read more

Pulmonary Fibrosis Linked to Stem Cell Failure

Cedars-Sinai investigators have pinpointed a major cause of pulmonary fibrosis, a mysterious and deadly disease that scars the lungs and obstructs breathing. The disease, which has no known cure, appears to result from the failure of special lung stem cells that help airways recover from injury, the investigators reported in the journal Nature Medicine. Paul W. Noble, MD, was the principal investigator, and Carol Liang, MD, was the first author for the study.

» Read more

New Director to Focus on Patient Experience

Alan Dubovsky

Alan Dubovsky has been appointed director of patient experience and chief patient experience officer at Cedars-Sinai, a new position to help coordinate service excellence initiatives. He assumed the post in late November.

» Read more

Daskivich Helps Lead Precision Medicine Study

Timothy Daskivich, MD, assistant professor and director of Health Services Research in the Cedars-Sinai Department of Surgery, has been named a co-investigator for a prostate cancer study funded by the California Initiative to Advance Precision Medicine. The study's goal is to create computer algorithms, using biomarker data, patient characteristics and tumor risk markers, to predict the effectiveness of various treatments for early-stage prostate cancer.

» Read more

Study Finds Few Share Fitness Data With Doctors

Personal fitness tracking, using devices such as Fitbit and the Apple Watch, may be all the rage, but getting users to share the data with their doctors is not easy, according to a new study by Cedars-Sinai investigators.

» Read more

Medical Staff Can Take Shot at Clippers Tickets

Medical staff can win tickets to an NBA game thanks to Cedars-Sinai's new partnership with the Los Angeles Clippers. Clippers tickets will be made available to Cedars-Sinai staff through a random drawing. Staff members may enter only once and can win only once this season.

» Read more

Core Labs to Switch to STAT Immunoassay Dec. 21

The Core laboratories in the Department of Pathology and Laboratory Medicine will switch from a standard PTH immunoassay to a STAT immunoassay beginning Wednesday, Dec. 21.

» Read more

CS-Link Tip: Access Available to CURES

cs-link logo

CS-Link™ now has access to the website of CURES (the Controlled Substance Utilization Review and Evaluation System).

» Read more

Core Labs Updating Reference Intervals Jan. 3

Beginning Jan. 3, the Core laboratories in the Department of Pathology and Laboratory Medicine will update cortisol and progesterone reference intervals to match new assay formulations and U.S. Food and Drug Administration-approved information provided by Roche Diagnostics.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news